Share This Page
Drug Price Trends for KETOPROFEN
✉ Email this page to a colleague
Average Pharmacy Cost for KETOPROFEN
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| KETOPROFEN ER 200 MG CAPSULE | 00378-8200-01 | 6.61864 | EACH | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Ketoprofen Market Analysis and Price Projections
Market Overview
Ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), is widely used for treating various types of pain, including arthritis, muscle pain, and menstrual discomfort. The market for ketoprofen, including its various forms such as tablets, capsules, gel, and transdermal patches, is experiencing significant growth driven by several key factors.
Global Market Size and Growth
The global ketoprofen market is projected to witness substantial growth over the next few years. Here are some key statistics:
- Global Ketoprofen Patches Market: The market size is estimated to be USD 102.6 million in 2024 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.20% from 2024 to 2031, reaching USD 146.30 million by 2031[1][4].
- Global Ketoprofen Market: The overall ketoprofen market is projected to grow from USD 36 million in 2024 to USD 40 million by 2030, at a CAGR of 1.9% during the forecast period[2].
Regional Market Analysis
The ketoprofen market is segmented across various regions, each with its own growth trajectory:
- North America: This region holds a significant market share, with the United States being a major contributor. The North American ketoprofen patches market is estimated at USD 41.04 million in 2024 and is expected to grow at a CAGR of 3.4% from 2024 to 2031[1].
- Europe: Europe accounts for more than 30% of the global revenue, with a market size of USD 30.78 million in 2024. It is expected to grow at a CAGR of 3.7% from 2024 to 2031[1].
- Asia-Pacific: This region holds around 23% of the global revenue, with a market size of USD 23.60 million in 2024. It is expected to grow at a CAGR of 7.2% from 2024 to 2031[1].
- Latin America: The Latin American market is smaller but growing, with a market size of USD 5.13 million in 2024 and a CAGR of 4.6% from 2024 to 2031[1].
- Middle East and Africa: This region holds around 2% of the global revenue, with a market size of USD 2.05 million in 2024 and a CAGR of 4.9% from 2024 to 2031[1].
Market Drivers
Several factors are driving the growth of the ketoprofen market:
- Increasing Incidences of Chronic Conditions: The rising prevalence of chronic diseases such as arthritis, muscle pain, and menstrual discomfort is driving the demand for effective pain management solutions like ketoprofen[5].
- Advancements in Drug Delivery Technologies: Innovations in drug delivery methods, such as transdermal patches and sustained-release formulations, are enhancing the effectiveness of ketoprofen and improving patient outcomes[5].
- Regulatory Support: Regulatory authorities' support for novel drug delivery methods is also boosting the market[1].
- OTC Availability: The over-the-counter (OTC) availability of ketoprofen is another factor fueling market growth[3].
Market Restraints
Despite the positive growth trends, there are some restraints to consider:
- Potential Side Effects: Ketoprofen can have side effects such as stomach upset, dizziness, constipation, and fluctuations in blood pressure, which can restrain market growth[3].
Market Segmentation
The ketoprofen market is segmented based on type and application:
- By Type: Ketoprofen tablets, capsules, gel, and others[3].
- By Application: Pain management, osteoarthritis, dysmenorrhea, gout, and others[3].
Key Players and Competitive Landscape
The market is dominated by several key players:
- SANOFI-Aventis, Boehringer-Ingelheim, BEC, Zhejiang Jiuzhou, and Hubei Xunda are some of the main players in the ketoprofen market[2].
- These companies are focusing on organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to expand their market share[3].
Innovations and Trends
Several trends and innovations are shaping the future of the ketoprofen market:
- Personalized Medicine: The shift towards personalized medicine is transforming pain management by allowing for targeted ketoprofen formulations based on genetic information and patient data[5].
- Strategic Partnerships: Collaborations between pharmaceutical companies and research institutions are driving innovation and the development of next-generation ketoprofen products[5].
- Sustainable Manufacturing Practices: There is an increasing focus on sustainable practices in the pharmaceutical industry, which is expected to influence the ketoprofen market in the future[5].
Price Projections
The pricing of ketoprofen products is influenced by several factors including production costs, regulatory approvals, and market demand.
- Ketoprofen Patches: The average price of ketoprofen patches can vary by region, but the overall market revenue is projected to increase due to growing demand and advancements in technology[1].
- Ketoprofen Tablets and Capsules: The prices of these formulations are generally stable but can fluctuate based on competition and regulatory changes[2].
Key Takeaways
- The global ketoprofen market is expected to grow significantly driven by increasing demand for pain management solutions and advancements in drug delivery technologies.
- Regional markets such as North America, Europe, and Asia-Pacific are key contributors to the global market.
- Innovations in personalized medicine and sustainable manufacturing practices are expected to shape the future of the market.
- Key players are focusing on strategic partnerships and product innovations to maintain market share.
Frequently Asked Questions (FAQs)
Q: What is the projected global market size for ketoprofen patches by 2031? A: The global ketoprofen patches market is expected to reach USD 146.30 million by 2031, growing at a CAGR of 5.20% from 2024 to 2031[1].
Q: Which region holds the largest market share for ketoprofen patches? A: North America holds the largest market share for ketoprofen patches, with a market size of USD 41.04 million in 2024[1].
Q: What are the main side effects associated with ketoprofen? A: Common side effects of ketoprofen include stomach upset, dizziness, constipation, fluctuations in blood pressure, and blurred vision[3].
Q: How is the shift towards personalized medicine impacting the ketoprofen market? A: The shift towards personalized medicine is allowing for targeted ketoprofen formulations based on genetic information and patient data, enhancing efficacy and safety[5].
Q: Which companies are the main players in the ketoprofen market? A: Key players include SANOFI-Aventis, Boehringer-Ingelheim, BEC, Zhejiang Jiuzhou, and Hubei Xunda[2].
Cited Sources
- Cognitive Market Research: Global Ketoprofen Patches Market Report 2024.
- Valuates Reports: Global Ketoprofen Market Insights, Forecast to 2030.
- The Insight Partners: Ketoprofen Market Developments by 2031.
- Cognitive Market Research: Ketoprofen Patches Market Insights Video.
- Market Research Intellect: Pharmaceutical Grade Ketoprofen Market Set to Surge.
More… ↓
